Somnolence: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 13: Line 13:


It is considered a lesser impairment of consciousness than [[stupor]] or [[coma]].
It is considered a lesser impairment of consciousness than [[stupor]] or [[coma]].
==Hypersomnia of Central Origin==
<ref>{{Cite web  | last =  | first =  | title = http://www.dsm5.org/Pages/Default.aspx | url = http://www.dsm5.org/Pages/Default.aspx | publisher =  | date =  | accessdate = }}</ref>


==Causes==
==Causes==
Line 62: Line 67:
**[[Triazolam]]
**[[Triazolam]]
**Benzodiazepine receptor agonists: [[Eszopiclone]], [[Zolpidem]], [[Zaleplon]]
**Benzodiazepine receptor agonists: [[Eszopiclone]], [[Zolpidem]], [[Zaleplon]]
**Melatonin receptor agonists: [[Ramelteon]]
**Melatonin receptor agonists: [[Ramelteon]]<ref>{{Cite web  | last =  | first =  | title = http://www.dsm5.org/Pages/Default.aspx | url = http://www.dsm5.org/Pages/Default.aspx | publisher =  | date =  | accessdate = }}</ref>


==Hazards==
==Hazards==

Revision as of 00:04, 10 March 2014

For patient information, click here

Somnolence
ICD-10 R40.0
ICD-9 780.09

Template:Search infobox Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Overview

Somnolence (or "drowsiness") is a state of near-sleep, a strong desire for sleep, or sleeping for unusually long periods. It has two distinct meanings, referring both to the usual state preceding falling asleep, and the chronic condition referring to being in that state independent of a circadian rhythm. The disorder characterized by the latter condition is most commonly associated with users of prescription hypnotics, such as mirtazapine or zolpidem.

It is considered a lesser impairment of consciousness than stupor or coma.

Hypersomnia of Central Origin

[1]

Causes

Hazards

Somnolence can be dangerous when performing tasks that require constant concentration, such as driving a vehicle. When a person is sufficiently fatigued, he or she may experience microsleeps (loss of concentration).

See also

References

  1. "http://www.dsm5.org/Pages/Default.aspx". External link in |title= (help)
  2. Zimmermann C, Pfeiffer H (January 2007). "[Sleep disorders in depression. Suggestions for a therapeutic approach]". Nervenarzt (in German). 78 (1): 21–30. doi:10.1007/s00115-006-2111-1. PMID 16832696.
  3. Watanabe N, Omori IM, Nakagawa A; et al. (2011). "Mirtazapine versus other antidepressive agents for depression". Cochrane Database Syst Rev (12): CD006528. doi:10.1002/14651858.CD006528.pub2. PMID 22161405.
  4. "http://www.dsm5.org/Pages/Default.aspx". External link in |title= (help)

Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:SleepSeries2

Template:Disease-stub